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Iconographic Essay
Uncommon hepatic tumors: iconographic essay – Part 1*
Tumores hepáticos incomuns: ensaio iconográfico – Parte 1




Most malignant liver tumors are represented by hepatocellular carcinoma and cholangiocarcinoma; however a variety of other uncommon
hepatic lesions might also be found. Common lesions such as hemangioma, focal nodular hyperplasia and metastases are well known
and have already been extensively documented in the literature. The diagnosis of typical hepatic lesions may be done with some reliability
by means of several imaging methods; on the other hand, uncommon lesions normally represent a diagnostic challenge for the radiologist.
In this first part of the study, the authors will approach five uncommon liver tumors – angiosarcoma, angiomyolipoma, cystadenoma/biliary
carcinoma, epithelioid hemangioendothelioma, and fibrolamellar hepatocellular carcinoma –, describing their main characteristics and
image findings with focus on computed tomography and magnetic resonance imaging.
Keywords: Neoplasms; Liver; Atypical; Computed tomography; Magnetic resonance imaging.
A maioria dos tumores hepáticos primários malignos é representada pelo carcinoma hepatocelular e pelo colangiocarcinoma, entretanto,
uma variedade de outras lesões hepáticas incomuns pode ser encontrada. Lesões comuns como o hemangioma, a hiperplasia nodular
focal e as metástases são bem conhecidas e já foram extensamente documentadas na literatura. O diagnóstico das lesões hepáticas
típicas pode ser feito com alguma segurança utilizando-se os diversos métodos de imagem; por outro lado, as lesões incomuns são
geralmente um desafio diagnóstico para o radiologista. Nesta primeira parte do estudo abordaremos cinco tumores hepáticos incomuns
– o angiossarcoma, o angiomiolipoma, o cistoadenoma/carcinoma biliar, o hemangioendotelioma epitelioide e o carcinoma hepatocelu-
lar fibrolamelar –, suas principais características e achados de imagem, com foco na tomografia computadorizada e na ressonância
magnética.
Unitermos: Neoplasias; Fígado; Atípicos; Tomografia computadorizada; Ressonância magnética.
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Among tumors considered uncommon, one highlights
epithelial tumors such as cystadenomas and biliary cystadeno-
carcinomas, non epithelial tumors including angiomyoli-
pomas, epithelioid hemangioendotheliomas and angiosarco-
mas, besides other such as lymphomas, inflammatory pseudo-
tumors (myofibroblastic tumors) and some sarcomas(3).
Few studies are available in the literature providing a
comparative and comprehensive analysis of imaging findings
of uncommon liver tumors.
The objective of this study is, by means of a pictorial es-
say, to describe the main imaging findings of several uncom-
mon benign and malignant liver tumors observed at computed
tomography (CT) and magnetic resonance magnetic (MRI).
ANGIOSARCOMA
It is the most common primary liver sarcoma, represent-
ing 2% of the malignant hepatic neoplasms, frequently af-
fecting patients in the sixth and seventh decades of life, with
prevalence in men (4 men:1 woman)(4). Patients with liver
angiosarcoma present a poor prognosis. At the moment of
the diagnosis, most of them have metastatic lesions, gener-
ally in the lungs and spleen (60% of cases), and a mean sur-
vival of six months(5).
The development of such tumors is associated with ex-
posure to chemical substances such as thorium dioxide, vi-
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INTRODUCTION
A wide range of tumors affect the liver, and 90% of the
focal liver lesions are benign. Among benign liver tumors,
hemangiomas and focal nodular hyperplasias are the most
common non-cystic lesions(1). Metastases are the most fre-
quently found malignant neoplasms; hepatocellular carcino-
mas being responsible for 80–85% of primary malignant
tumors, followed by intrahepatic cholangiocarcinomas(2).
The diagnosis of typical liver lesions can be safely made
with different imaging methods; by contrast, uncommon
lesions generally represent a diagnostic challenge for radi-
ologists.
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nyl chloride and arsenic and, in some cases is related to
hemochromatosis and use of anabolic steroids(5,6).
The pathological evaluation of angiosarcomas may dem-
onstrate four growth patterns, as follows: multiple nodules;
dominant mass; mixed pattern (dominant mass with nodules);
and diffuse micronodular infiltration. Among such patterns,
the multinodular and the diffuse micronodular infiltration
patterns are most commonly observed(4).
Imaging findings vary, which reflects the diverse histo-
logical composition of the lesions(7). At ultrasonography
(US), one may observe a heterogeneous mass (Figure 1),
eventually with hyperechogenic areas with posterior acous-
tic shadowing, indicating the presence of calcifications(8).
At CT, most lesions are hypodense at the non contrast-en-
hanced phase, but some of them may be hyperattenuating
due to the presence of areas of intralesional bleeding. After
intravenous contrast injection, at the arterial and portal
phases, they may present focal areas of central and ring-
shaped heterogeneous enhancement persistent and progres-
sive at delayed phases, in addition to possible calcifications(4)
(Figure 2). Recent studies have demonstrated that angiosa-
rcomas do not present the same progressive centripetal en-
hancement of cavernous hemangiomas, differently from de-
scriptions in earlier studies, so both entities can be safely
differentiated by imaging methods(4,5).
At MRI, such tumors may demonstrate areas with
hypersignal on T1-weighted sequences, and heterogeneous
Figure 2. Angiosarcoma. Abdominal CT. At the non-contrast-enhanced phase, the presence of hypodense and heterogeneous liver masses is identified, intermingled
with foci of calcifications. The largest of such masses occupies the whole right liver lobe (A). At the arterial phase, the mass presents intense enhancement by the
iodinated contrast agent, representing hypervascularization (B), which remains at the portal (C) and delayed (D) phases.
Figure 1. Angiosarcoma. Ultrasonography demonstrates the presence of a pre-
dominantly hyperechogenic, heterogeneous hepatic mass occupying the whole
right liver lobe.
RIGHT LIVER LOBE
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aspect on T2-weighted sequences, with foci of hemorrhage,
fibrotic septa or intermixed calcifications, presenting early
and progressive enhancement(5).
Main differential diagnoses include epithelioid heman-
gioendothelioma, intrahepatic cholangiocarcinoma and
hypervascular metastasis(4).
Main aspects favoring the diagnosis of hepatic angiosa-
rcoma include:
• Men at the sixth and seventh decades of life.
• History of exposure to chemical substances such as tho-
rium dioxide, vynil chloride and arsenic, and anabolic
steroids.
• Heterogeneous, hypervascular masses with persistent en-
hancement.
ANGIOMYOLIPOMA
Angiomyolipoma is a rare mesenchymal tumor with
varied histological components such as fat tissue, smooth
muscle and vessels(7). Recent studies suggest that angiomyo-
lipoma is not a mesenchymal lesion, but a neoplasia origi-
nating from perivascular epithelioid cells, classified by the
World Health Organization as PEComa (“perivascular epi-
thelioid cells” tumor)(8). It occurs more frequently in middle
aged women and 50% of patients are asymptomatic. Symp-
toms are observed in cases where intralesional bleeding is
present, which generally occurs in lesions > 5.0 cm. There
is neither association with tuberous sclerosis nor with renal
angiomyolipomas. Most patients do not present hepatopa-
thy and tumor markers (CEA and CA 19-9) are negative(7,8).
Due to the presence of different histological components,
hepatic angiomyolipoma presents variable imaging features,
many times resembling those of hepatocarcinoma. The diag-
nosis is preoperatively suspected in only 11% to 25% of cases,
respectively by CT and MRI(9). At US, the lesion may ap-
pear hyperechogenic and homogeneous, similar to heman-
gioma (Figure 3). At CT and MRI, in the presence of a
sufficient amount of intralesional fat, one can identify it with
basis on the negative CT density and signal drop on out-of-
phase gradient-echo sequence (Figure 4). Main differential
diagnoses include fatty liver lesions such as adenoma, hepa-
tocellular carcinoma, lipoma and liposarcoma(9).
Main aspects to be considered in the diagnosis of
angiomyolipomas include:
• Middle aged women.
• CT and MRI findings similar to those of hepatocellular
carcinoma, without hepatopathies and with negative tu-
mor markers.
• Presence of intralesional fat.
CYSTADENOMA AND BILIARY
CYSTADENOCARCINOMA
Biliary cystadenomas are uncommon and represent less
than 5% of all uni- or multilocular cysts of biliary origin(10).
Generally, most of these lesions are intrahepatic (85% of
cases), with diameter ranging from 1.5 cm to 35 cm and
predilection for the right liver lobe(9). Predominantly, such
lesions affect middle aged women and in less than 5% of cases
are considered to be pre-malignant lesions(11). Symptoms,
if present, are associated with mass-effect and consist in in-
termittent pain or jaundice(12).
Macroscopically, the lesion is cystic, with fluid or mu-
cinous content. Hemorrhagic, biliary, mixed and even pu-
rulent content may be found. At histological analysis, the epi-
thelium shows papillary projections or polyps, besides ova-
rian stromal cells in female patients(9).
At CT and MRI, such lesions present as a solitary cystic
mass with a well defined fibrous capsule, mural nodules, in-
ternal septa, calcifications and fluid-fluid level(9) (Figures 5
and 6).
Main differential diagnoses include hydatid cyst, cystic
metastasis and abscess(9).
Main aspects to be considered in the diagnosis of bil-
iary cystadenoma include:
• Middle aged women.
• Solitary cystic mass with internal septa, mural nodules
and calcifications.
EPITHELIOID HEMANGIOENDOTHELIOMA
It is a malignant tumor of vascular origin affecting adult
individuals, particularly women since estrogen is an associ-
ated risk factor. It is considered an insidious neoplasm of
intermediate to low grade malignancy and, on average, a five-
year survival rate is about 50%(13,14).
Clinical findings are nonspecific and include right hy-
pochondrium pain and weight loss, and in some cases may
progress with fulminant hepatitis or Budd-Chiari syndrome(13).
Most common metastasis sites include abdominal lymph
nodes, peritoneum, lungs and bones(14).
Epithelioid hemangioendotheliomas have the following
imaging presentations: nodular and diffuse. The multinodu-
lar presentation represents the initial phase of the disease,
when frequently subcapsular nodules with varied sizes and
peripheral distribution are found. On the other hand, in late
Figure 3. Angiomyolipoma. Ultrasonography demonstrates the presence of
hyperechogenic liver mass with lobulated contours and central flow at Doppler,
located in the segments VII/VIII.
Pedrassa BC et al. / Uncommon hepatic tumors: iconographic essay – Part 1
Radiol Bras. 2014 Set/Out;47(5):310–316 313
phases, the nodules grow and coalesce, forming extensive
and infiltrative lesions(6).
After intravenous contrast injection, the lesions may
present peripheral and central enhancement, corresponding
to capsular retraction and calcifications within the lesion can
be noted (Figure 7). Alomari have described the so called
“lollipop sign” that can be observed at CT and MRI, corre-
sponding to abrupt termination of the portal vein or hepatic
artery in the mass periphery and representing a specific find-
ing of this entity(15).
Figure 5. A 42-year-old female patient with no previous history of disease, com-
plaining of a painful, palpable mass in the epigastrium. Contrast-enhanced CT
portal phase demonstrates cystic multiloculated lesion, with thick internal septa
enhanced after contrast injection. The diagnosis was biliary cystadenocarcinoma.
Figure 6. Biliary cystadenoma. Contrast-enhanced CT portal phase demonstrates
cystic lesion with fine internal septa intermingled with foci of calcification.
Figure 4. Angiomyolipoma. At abdominal MRI,
the lesion presents subtle hypersignal on T1-
weighted (A) and non homogeneous hypersignal
on T2-weighted (B) sequences. At the out-of-
phase sequence, marked signal dropout is ob-
served, indicating fat component (C). After para-
magnetic contrast injection, atypical enhance-
ment is observed (D).
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Pulmonary metastases generally calcify and bone me-
tastases are osteolytic, insufflating and with marginal scle-
rosis (Figures 7 and 8).
Main aspects to be considered in the diagnosis of epi-
thelioid hemangioendothelioma include:
• Adult women undergoing estrogen therapy.
• Presence of multiple peripheral nodules with capsular
retraction.
• Calcified pulmonary metastasis.
• Lollipop sign.
FIBROLAMELLAR HEPATOCARCINOMA
It is a primary malignant tumor corresponding to 1–9%
of all tumors of hepatocellular origin. Clinical, laboratory,
histopathological and imaging findings differentiate this
tumor from the conventional hepatocellular carcinoma. It
occurs preferentially in adolescent patients or in young adults
with neither underlying hepatopathy nor increasing in tumor
markers such as alpha-fetoprotein(16).
Almost all cases are incidentally diagnosed at late stages
of the disease, since it is asymptomatic. However, pain, pal-
pable abdominal mass and ascites are most commonly ob-
served in symptomatic cases (40% of cases)(16).
Frequent CT and MRI findings of fibrolamellar hepa-
tocellular carcinomas include large solitary lobulated and
well defined mass (80% of cases) in non cirrhotic liver which,
in 50% of the cases cause biliary tract dilatation. After intra-
venous contrast agent injection, such lesions present hetero-
geneous hypervascular enhancement, with radiating septa and
central scar (70% of cases) with a fibrotic component that
presents delayed enhancement, which is helpful to differen-
tiate this tumor from focal nodular hyperplasia. Metastasis
Figure 7. Epithelioid hemangioendothelioma. Non-contrast-enhanced abdominal CT identifies the presence of hypodense peripheral hepatic nodules intermingled with
foci of calcifications (arrow on A), which may occur in up to 25% of cases. Chest CT of the same patient (B) demonstrates the presence of sparse secondary nodules
randomly distributed on the pulmonary parenchyma. At abdominal CT portal phase (C,D) hepatic nodules present with more intense enhancement in the periphery of
the lesion, hepatic capsule retraction (arrow on C), besides calcified lung metastases (arrow on D).
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occurs in 30% of cases, most frequently in lungs and adre-
nal glands(17).
Calcifications are found in about 50% of cases investi-
gated by CT and almost exclusively in the region of the cen-
tral scar, differently from focal nodular hyperplasia where
calcifications are extremely rare(17) (Figure 9).
Main aspects to be considered in the diagnosis of
fibrolamellar hepatocellular carcinoma include:
• Young individuals with no history of hepatopathy and
negative tumor markers.
• Presence of large hepatic, hypervascular mass with
central scar and calcifications.
Figure 8. Epithelioid hemangioendothelioma. A: Abdominal CT portal phase demonstrates the presence of hypovascular peripheral hepatic nodules. MRI demonstrates
that the hepatic nodule presents low signal intensity at T1-weighted sequences (B) and high signal intensity at T2-weighted with target sign (C). At pelvic CT, insufflating




Figure 9. A 23-year-old woman with no hepatopathy and negative tumor markers and with fibrolamellar hepatocellular carcinoma. Non-contrast-enhanced CT (A)
arterial (B) and equilibrium (C) phases demonstrate the presence of a subtly hypodense large mass in the right liver lobe, with central punctiform calcifications presenting
heterogeneous hypervascular enhancement with progressive appearance in its central region, intermingled with necrotic areas.
A B C
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CONCLUSION
Radiological findings of the most common liver lesions
are well known and widely described in the literature. On
the other hand, scarce studies are found in the literature con-
solidating the main information regarding more rare liver
tumors and lesions(18–22).
In this first part of the present study, the authors describe
the main clinical-radiological characteristics of these rare
tumors. Although in the great majority of cases, the defini-
tive diagnosis must be confirmed by histopathological analy-
sis, the imaging findings can raise the diagnostic suspicion,
hence the relevance of familiarity with such radiological find-
ings to reduce the list of differential diagnoses and increase
the chances for a more accurate radiological evaluation.
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